RGD Peptide-Conjugated Selenium Nanocomposite Inhibits Human Glioma Growth by Triggering Mitochondrial Dysfunction and ROS-Dependent MAPKs Activation

Chemotherapy is still one of the most common ways to treat human glioblastoma in clinic. However, severe side effects limited its clinic application. Design of cancer-targeted drugs with high efficiency and low side effect is urgently needed. Herein, silver nanoparticles (Ag NPs) and nano-selenium (...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wenjian, Su, Jing, Shi, Qiang, Wang, Jinlei, Chen, Xiao, Zhang, Shizhong, Li, Mengkao, Cui, Jie, Fan, Cundong, Sun, Beibei, Wang, Guojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733670/
https://www.ncbi.nlm.nih.gov/pubmed/35004643
http://dx.doi.org/10.3389/fbioe.2021.781608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733670/
https://www.ncbi.nlm.nih.gov/pubmed/35004643
http://dx.doi.org/10.3389/fbioe.2021.781608

Ejemplares similares